Eosinophilic Myocarditis

@article{Cheung2017EosinophilicM,
  title={Eosinophilic Myocarditis},
  author={C. Cheung and Maggie Constantine and A. Ahmadi and C. Shiau and Luke Y C Chen},
  journal={The American Journal of the Medical Sciences},
  year={2017},
  volume={354},
  pages={486–492}
}
ABSTRACT Persistent eosinophilia can cause cardiac tissue damage, typically in the form of eosinophilic myocarditis, whether the underlying cause is reactive, a clonal myeloid disorder, or idiopathic hypereosinophilic syndrome (HES). Eosinophilic myocarditis ranges from mild localized disease to multifocal widespread infiltrates associated with myocardial necrosis, thrombotic complications and endomyocardial fibrosis. Systemic treatment varies widely depending on the underlying cause, so… Expand
Characterization of a Mouse Model of Hypereosinophilia-Associated Heart Disease.
TLDR
The pathologies observed in the mutant lines are reminiscent of those seen in patients with hypereosinophilia, where cardiac-related morbidities, like congestive heart failure and thrombi, are the most common causes of death and the model provides an opportunity to test mechanistic hypotheses and develop targeted therapies. Expand
Giant Cell and Hypersensitivity Myocarditis
Giant cell myocarditis (GCM) and hypersensitivity myocarditis (HSM) are both rare inflammatory diseases of the myocardium that are rapidly progressive and carry poor prognosis. Histologically bothExpand
Causes of hypereosinophilia in 100 consecutive patients.
TLDR
Most patients with HE/HES were found to have a discrete secondary cause of eosinophilia and only 14 were deemed idiopathic, highlighting the importance of extensive evaluation for secondary causes of eOSinophile such as L-HES, IgG4-RD, and EGPA. Expand
Cardiovascular disease in the Systemic Vasculitides.
TLDR
An overview of the pathogenetic, diagnostic and therapeutic principles of cardiovascular involvement disease in the various forms of systemic vasculitis is provided. Expand
A case of suspected eosinophilic myocarditis recognized by a fully noninvasive approach and safely treated with corticosteroids despite an underling Hepatitis C virus-hepatitis.
TLDR
In the opinion EM can be correctly recognized without endomyocardial biopsy and so promptly and safely treated with corticosteroids, even when an underling mild HCV-hepatitis is present. Expand
Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia.
TLDR
An in-depth review of the classification and diagnostic evaluation of hypereos inophilia (HE), with a focus on eosinophilic neoplasms, is provided to ensure prompt and accurate diagnosis and to help optimize patient care. Expand
Clinical Management and Follow-Up of Myocarditis Patients on Immunosuppressive Therapy
TLDR
This chapter deals with general definition and basic principles of IT, preparatory patient workup (Safety Checklist) in IT candidates with autoimmune acute myocarditis (AM)/dilated cardiomyopathy (DCM), traditional and innovative IT regimens in AM/DCM, patient follow-up and therapeutic patient education (TPE) to self-management. Expand
Case Report of Fulminant Eosinophilic Myocarditis With Concomitant Pheochromocytoma.
TLDR
This case highlights the need for a comprehensive diagnostic workup for acute cardiomyopathy manifesting as cardiogenic shock in young patients and the benefit of early initiation of mechanical support facilitating both diagnosis and recovery. Expand
An illustrative case of endocardial fibroelastosis and recalcitrant intracardiac thrombosis: a case report
TLDR
A relatively asymptomatic patient with endocardial fibroelastosis who has been found to have atrial fibrillation and a large thrombus in the right atrium is described. Expand
Role of Inflammatory Cell Subtypes in Heart Failure
TLDR
A better understanding of the temporal course of the infiltration of the different immune cells and their contribution to the inflammatory process may improve the success for therapy. Expand
...
1
2
...

References

SHOWING 1-10 OF 66 REFERENCES
Eosinophilic myocarditis: case series and literature review
TLDR
EOSinophilic myocarditis is one of the most fatal complications of hypereosinophilia and has been rarely reported in the literature, particularly in Asia Pacific regions, reflecting the under-recognition of the disease. Expand
A case report of eosinophilic myocarditis and a review of the relevant literature
TLDR
Myocardial biopsy is helpful in diagnosing the disease in the early stages and high-dose corticosteroids effectively improves the prognosis of this disease. Expand
Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis.
TLDR
The cardiac involvement is characterized by a subacute course and symptoms of congestive heart failure and treatment with glucocorticoids and cytotoxic agents is effective. Expand
Eosinophilic Granulomatosis with Polyangiitis (Churg‐Strauss)
TLDR
Recent advances in EGPA management, including several novel immunomodulatory drugs and targeted biotherapies, were or are being evaluated to improve EGPA patients' prognoses. Expand
Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment.
TLDR
It is demonstrated that eosinophilic myocarditis may simulate acute myocardial infarction and should be considered in patients with a history of allergies or acute left ventricular dysfunction, even in the absence of pronounced eos inophilia in the peripheral blood. Expand
Eosinophilic myocarditis
TLDR
It is believed that a clinical spectrum of the disease exists that is intimately correlated with the number of eosinophils and especially the degree of activation and an important step will have been taken toward both the understanding and the treatment of this disease spectrum. Expand
Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis
TLDR
Endomyocardial biopsy needs to be performed in most cases in order to establish a definitive diagnosis of EM, and Immunosuppressive therapy represents the treatment mainstay in the majority of EM forms. Expand
Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib.
TLDR
Clinicians should be aware of the variable heart manifestations in patients with HES and the potential cardiotoxicity of imatinib, as this patient suffered a severely left ventricular dysfunction that was restablished after early drug withdrawal. Expand
Eosinophilic myocarditis: case series and review of literature.
TLDR
Three cases of biopsy-proven EM with different presentations, including acute coronary syndrome, cardiogenic shock and newly diagnosed heart failure are described, with a complete recovery of the ventricular function in all cases. Expand
Cardiovascular manifestations of hypereosinophilic syndromes.
TLDR
The diagnosis and management of the cardiovascular manifestations of HES are reviewed, including endomyocardial fibrosis, which is the most characteristic cardiovascular abnormality in HES. Expand
...
1
2
3
4
5
...